# ABTECT - Maintenance

> **NCT05535946** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Abivax S.A.** · enrollment: 1116 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** ABX464
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05535946
- **Lead sponsor:** Abivax S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-16
- **Primary completion:** 2026-04
- **Final completion:** 2030-05
- **Target enrollment:** 1116 (ACTUAL)
- **Last updated:** 2025-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05535946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05535946, "ABTECT - Maintenance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05535946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*